XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Balance Sheet Components    
Accrued commercial and research and development manufacturing $ 51,523 $ 30,541
Accrued co-development costs payable to Junshi Biosciences 17,544 1,926
Lease liabilities, current 4,097 3,492
Accrued other 12,826 12,168
Total Accrued and other current liabilities $ 85,990 $ 48,127